Ginwa Enterprise Group Inc (600080) - Total Liabilities
Based on the latest financial reports, Ginwa Enterprise Group Inc (600080) has total liabilities worth CN¥370.80 Million CNY (≈ $54.26 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Ginwa Enterprise Group Inc to track the company's year-over-year net asset growth rate.
Ginwa Enterprise Group Inc - Total Liabilities Trend (1994–2025)
This chart illustrates how Ginwa Enterprise Group Inc's total liabilities have evolved over time, based on quarterly financial data. See Ginwa Enterprise Group Inc (600080) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Ginwa Enterprise Group Inc Competitors by Total Liabilities
The table below lists competitors of Ginwa Enterprise Group Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Eaton Vance National Municipal Opportunities Closed Fund
NYSE:EOT
|
USA | $40.82 Million |
|
Praemium Ltd
AU:PPS
|
Australia | AU$19.53 Million |
|
Zhangjiagang Haiguo New Energy Equipment Manufacturing Co. Ltd.
SHE:301063
|
China | CN¥1.09 Billion |
|
Beijing Bohui Science & Technology Co Ltd
SHG:688004
|
China | CN¥98.57 Million |
|
Eledon Pharmaceuticals Inc
NASDAQ:ELDN
|
USA | $100.82 Million |
|
Eagle Point Income Company Inc
NYSE:EIC
|
USA | $169.02 Million |
|
Calamos LongShort Equity & Dynamic Income Trust
NASDAQ:CPZ
|
USA | $344.59 Million |
|
Putnam Managed Municipal Income Closed Fund
NYSE:PMM
|
USA | $19.31 Million |
Liability Composition Analysis (1994–2025)
This chart breaks down Ginwa Enterprise Group Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 600080 market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.19 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ginwa Enterprise Group Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ginwa Enterprise Group Inc (1994–2025)
The table below shows the annual total liabilities of Ginwa Enterprise Group Inc from 1994 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥369.61 Million ≈ $54.09 Million |
-10.42% |
| 2024-12-31 | CN¥412.59 Million ≈ $60.37 Million |
-12.24% |
| 2023-12-31 | CN¥470.12 Million ≈ $68.79 Million |
+61.75% |
| 2022-12-31 | CN¥290.65 Million ≈ $42.53 Million |
+35.84% |
| 2021-12-31 | CN¥213.97 Million ≈ $31.31 Million |
-9.81% |
| 2020-12-31 | CN¥237.24 Million ≈ $34.71 Million |
-10.18% |
| 2019-12-31 | CN¥264.12 Million ≈ $38.65 Million |
+29.88% |
| 2018-12-31 | CN¥203.36 Million ≈ $29.76 Million |
-32.37% |
| 2017-12-31 | CN¥300.69 Million ≈ $44.00 Million |
-18.77% |
| 2016-12-31 | CN¥370.18 Million ≈ $54.17 Million |
+74.51% |
| 2015-12-31 | CN¥212.13 Million ≈ $31.04 Million |
-13.96% |
| 2014-12-31 | CN¥246.55 Million ≈ $36.08 Million |
+32.05% |
| 2013-12-31 | CN¥186.71 Million ≈ $27.32 Million |
+15.37% |
| 2012-12-31 | CN¥161.83 Million ≈ $23.68 Million |
+7.45% |
| 2011-12-31 | CN¥150.62 Million ≈ $22.04 Million |
-78.57% |
| 2010-12-31 | CN¥702.81 Million ≈ $102.84 Million |
+2.73% |
| 2009-12-31 | CN¥684.14 Million ≈ $100.11 Million |
+1.36% |
| 2008-12-31 | CN¥674.93 Million ≈ $98.76 Million |
-26.53% |
| 2007-12-31 | CN¥918.70 Million ≈ $134.43 Million |
-24.39% |
| 2006-12-31 | CN¥1.22 Billion ≈ $177.81 Million |
-19.30% |
| 2005-12-31 | CN¥1.51 Billion ≈ $220.34 Million |
+54.61% |
| 2004-12-31 | CN¥973.91 Million ≈ $142.51 Million |
+63.91% |
| 2003-12-31 | CN¥594.19 Million ≈ $86.95 Million |
+23.17% |
| 2002-12-31 | CN¥482.42 Million ≈ $70.59 Million |
+2.40% |
| 2001-12-31 | CN¥471.11 Million ≈ $68.94 Million |
+92.73% |
| 2000-12-31 | CN¥244.44 Million ≈ $35.77 Million |
+38.95% |
| 1999-12-31 | CN¥175.92 Million ≈ $25.74 Million |
+153.35% |
| 1998-12-31 | CN¥69.44 Million ≈ $10.16 Million |
+42.97% |
| 1997-12-31 | CN¥48.57 Million ≈ $7.11 Million |
-48.71% |
| 1996-12-31 | CN¥94.69 Million ≈ $13.86 Million |
+282.87% |
| 1995-12-31 | CN¥24.73 Million ≈ $3.62 Million |
+114.82% |
| 1994-12-31 | CN¥11.51 Million ≈ $1.68 Million |
-- |
About Ginwa Enterprise Group Inc
Ginwa Enterprise (Group) Inc. researches, develops, produces, markets, and sells traditional Chinese medicines, biological drugs, and chemical drugs primarily in China. The company offers a range of orthopaedics, immunity, children, and general medicines in various dosage forms, including tablets, capsules, granules, powders, mixtures, oral solutions, syrups, and external solutions. It is also in… Read more